Later, with an IC50 value of 0.43 ± 0.07 μM, cirsimaritin was found to be a potent inhibitor of dipeptidyl peptidase IV (DPP-IV enzyme) for the management of type 2 diabetes [151]. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.